Ana Vallejo, Author at Myeloma Patients Europe - Page 9 of 23

Helping patients reclaim a life of possibility

Ana Vallejo

test

Picture of the awards given 1

Happy anniversary AMILO!

MPEMarch 8, 2023

Job offer – Medical and Scientific officer

MPEMarch 1, 2023

T2EVOLVE and QUALITOP launch European patient survey on CAR-T treatment

MyelomaMarch 1, 2023

AMEN daratumumab cover

Daratumumab approved for first line treatment in Israel

MPE, MyelomaJanuary 30, 2023

Study shows the importance of vaccination for myeloma patients

MyelomaJanuary 26, 2023

ASH 2022 | Myeloma and AL amyloidosis updates

AL amyloidosis, Conferences, Myeloma, VideosDecember 12, 2022

Anxiety, depression and quality of life tied to caregivers’ coping mechanisms

MPENovember 21, 2022

Join MPE’s webinar on Access Barriers to Clinical Trials in CEE Countries

Access, MPEOctober 20, 2022

The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myeloma

Access, MyelomaAugust 30, 2022

Meet Lise-Lott Eriksson, president of Myeloma Patients Europe (MPE)

MPEAugust 18, 2022